{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:38:41Z","timestamp":1793198321934,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["2023BCB138"],"award-info":[{"award-number":["2023BCB138"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007925","name":"Huazhong Agricultural University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002354"],"award-info":[{"award-number":["82002354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072500"],"award-info":[{"award-number":["82072500"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003397","name":"Huazhong University of Science and Technology","doi-asserted-by":"publisher","award":["YCJJ202201022"],"award-info":[{"award-number":["YCJJ202201022"]}],"id":[{"id":"10.13039\/501100003397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.cmet.2024.03.005","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T11:03:22Z","timestamp":1712055802000},"page":"1679-1695.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis"],"prefix":"10.1016","volume":"36","author":[{"given":"Yimin","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renpeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuben","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-an","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meipeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2024.03.005_bib1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/CORR.0000000000002465","article-title":"What was the epidemiology and global burden of disease of hip fractures from 1990 to 2019? Results from and additional analysis of the Global Burden of Disease Study 2019","volume":"481","author":"Dong","year":"2023","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.cmet.2024.03.005_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.spinee.2021.12.007","article-title":"Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019","volume":"22","author":"Dong","year":"2022","journal-title":"Spine J."},{"key":"10.1016\/j.cmet.2024.03.005_bib3","doi-asserted-by":"crossref","first-page":"870905","DOI":"10.3389\/fendo.2022.870905","article-title":"Global, regional, and national burden of low bone mineral density From 1990 to 2019: results from the Global Burden of Disease Study 2019","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cmet.2024.03.005_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella","year":"2014","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cmet.2024.03.005_bib5","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00198-009-1134-4","article-title":"Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis","volume":"21","author":"Imaz","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cmet.2024.03.005_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12929-015-0212-5","article-title":"Role of Nrf2 in bone metabolism","volume":"22","author":"Sun","year":"2015","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.cmet.2024.03.005_bib7","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/jcp.29219","article-title":"Nrf2-ARE signaling in cellular protection: mechanism of action and the regulatory mechanisms","volume":"235","author":"Shaw","year":"2020","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.cmet.2024.03.005_bib8","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s40265-019-01229-3","article-title":"Dimethyl fumarate: a review in relapsing-remitting MS","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.cmet.2024.03.005_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tips.2023.03.005","article-title":"Omaveloxolone (Skyclarys\u2122) for patients with Friedreich's ataxia","volume":"44","author":"Dayalan Naidu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cmet.2024.03.005_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cmet.2024.03.005_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.apsb.2015.05.008","article-title":"Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents","volume":"5","author":"Abed","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cmet.2024.03.005_bib12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S2215-0366(16)30344-3","volume":"3","author":"Bugarski-Kirola","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cmet.2024.03.005_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopsych.2016.11.014","article-title":"Bitopertin in negative symptoms of schizophrenia-results from the phase III FlashLyte and DayLyte studies","volume":"82","author":"Bugarski-Kirola","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cmet.2024.03.005_bib14","series-title":"Study of bitopertin to evaluate the safety, tolerability, efficacy, and PPIX concentrations in participants with EPP","year":"2022"},{"key":"10.1016\/j.cmet.2024.03.005_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jbmr.4240","article-title":"Metabolomics insights into osteoporosis through association with bone mineral density.","volume":"36","author":"Zhang","year":"2021","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.cmet.2024.03.005_bib16","first-page":"e5021","article-title":"Serum glycine levels are associated with cortical bone properties and fracture risk in men","volume":"106","author":"Eriksson","year":"2021","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.03.005_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cmet.2019.01.014","article-title":"Serine metabolism supports macrophage IL-1beta production","volume":"29","author":"Rodriguez","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.03.005_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamapsychiatry.2014.163","article-title":"Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study","volume":"71","author":"Umbricht","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cmet.2024.03.005_bib19","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00213-016-4317-7","article-title":"Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteers","volume":"233","author":"Hofmann","year":"2016","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.cmet.2024.03.005_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4306\/pi.2017.14.1.63","article-title":"Efficacy and safety of bitopertin in patients with schizophrenia and predominant negative symptoms: subgroup analysis of Japanese patients from the global randomized phase 2 trial","volume":"14","author":"Hirayasu","year":"2017","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.cmet.2024.03.005_bib21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjh.17479","article-title":"Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent beta-thalassaemia","volume":"194","author":"Taher","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cmet.2024.03.005_bib22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.cmet.2024.03.005_bib23","doi-asserted-by":"crossref","first-page":"e130111","DOI":"10.1172\/jci.insight.130111","article-title":"Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of beta-thalassemia","volume":"4","author":"Matte","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.cmet.2024.03.005_bib24","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2215\/CJN.02400222","article-title":"Effects of bardoxolone methyl in alport syndrome","volume":"17","author":"Warady","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cmet.2024.03.005_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186723","article-title":"Pathogenic mechanisms of myeloma bone disease and possible roles for NRF2","volume":"21","author":"Yen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmet.2024.03.005_bib26","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1038\/ncomms5926","article-title":"Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis","volume":"5","author":"Benyamin","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2024.03.005_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s42003-020-01575-z","article-title":"A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis","volume":"4","author":"Bell","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cmet.2024.03.005_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12031-021-01913-8","article-title":"Evidence that HFE H63D variant is a potential disease modifier in cluster headache","volume":"72","author":"Papasavva","year":"2022","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.cmet.2024.03.005_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s42255-020-0191-z","article-title":"NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism","volume":"2","author":"Fox","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2024.03.005_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s42255-021-00406-7","article-title":"Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells","volume":"3","author":"Schwartz","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2024.03.005_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopha.2016.12.024","article-title":"Ornithine and its role in metabolic diseases: an appraisal","volume":"86","author":"Sivashanmugam","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cmet.2024.03.005_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2024.03.005_bib33","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.kint.2019.04.027","article-title":"Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease","volume":"96","author":"Rossing","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.cmet.2024.03.005_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe Study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cmet.2024.03.005_bib35","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1021\/acs.jmedchem.8b00358","article-title":"Non-covalent small-molecule kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting central nervous system diseases","volume":"61","author":"Pallesen","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.cmet.2024.03.005_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2019.12.012","article-title":"Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis","volume":"148","author":"Zhang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cmet.2024.03.005_bib37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3389\/fphar.2020.01175","article-title":"Schisandrin B inhibits osteoclastogenesis and protects against ovariectomy-induced bone loss","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cmet.2024.03.005_bib38","doi-asserted-by":"crossref","first-page":"101309","DOI":"10.1016\/j.redox.2019.101309","article-title":"The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-\u03baB signaling","volume":"28","author":"Sun","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.cmet.2024.03.005_bib39","doi-asserted-by":"crossref","first-page":"114101","DOI":"10.1016\/j.biopha.2022.114101","article-title":"Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS\/Keap1\/Nrf2 signalling axis and osteoclastogenesis","volume":"159","author":"Xu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cmet.2024.03.005_bib40","doi-asserted-by":"crossref","first-page":"114761","DOI":"10.1016\/j.bcp.2021.114761","article-title":"Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation","volume":"193","author":"Xian","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cmet.2024.03.005_bib41","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3324\/haematol.2009.020123","article-title":"Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE\/ARE sequence motif at position -7007 of the FPN1 promoter","volume":"95","author":"Marro","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.cmet.2024.03.005_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.metabol.2018.01.005","article-title":"Iron-induced oxidative stress stimulates osteoclast differentiation via NF-\u03baB signaling pathway in mouse model","volume":"83","author":"Wang","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.cmet.2024.03.005_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s42255-019-0063-6","article-title":"Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin","volume":"1","author":"Lim","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2024.03.005_bib44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/jbmr.5650040615","article-title":"Inhibition of bone resorption by alpha-difluoromethylornithine may not be mediated by polyamine depletion","volume":"4","author":"Lucas","year":"1989","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.cmet.2024.03.005_bib45","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases","volume":"136","author":"Filleul","year":"2010","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cmet.2024.03.005_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11914-022-00771-6","article-title":"Denosumab discontinuation","volume":"21","author":"S\u00f8lling","year":"2023","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.cmet.2024.03.005_bib47","doi-asserted-by":"crossref","first-page":"106513","DOI":"10.1016\/j.phrs.2022.106513","article-title":"Blocking the cytohesin-2\/ARF1 axis by SecinH3 ameliorates osteoclast-induced bone loss via attenuating JNK-mediated IRE1 endoribonuclease activity","volume":"185","author":"Dong","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cmet.2024.03.005_bib48","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00210-022-02378-1","article-title":"Pharmacokinetic profile of bitopertin, a selective GlyT1 inhibitor, in the rat","volume":"396","author":"Frouni","year":"2023","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.cmet.2024.03.005_bib49","doi-asserted-by":"crossref","first-page":"R1387","DOI":"10.1152\/ajpregu.00159.2004","article-title":"Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats","volume":"287","author":"El Hafidi","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.cmet.2024.03.005_bib50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-007-0976-8","article-title":"Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls","volume":"196","author":"Leung","year":"2008","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.cmet.2024.03.005_bib51","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00726-020-02901-9","article-title":"Obesity increases hepatic glycine dehydrogenase and aminomethyltransferase expression while dietary glycine supplementation reduces white adipose tissue in Zucker diabetic fatty rats","volume":"52","author":"Simmons","year":"2020","journal-title":"Amino Acids"},{"key":"10.1016\/j.cmet.2024.03.005_bib52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1474-4422(22)00209-5","article-title":"Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial","volume":"21","author":"Svenningsson","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cmet.2024.03.005_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.339","article-title":"Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1","volume":"7","author":"Kang","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2024.03.005_bib54","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0016-5085(92)90745-K","article-title":"Luminal polyamines substitute for tissue polyamines in duodenal mucosal repair after stress in rats","volume":"102","author":"Wang","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.03.005_bib55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.cmet.2024.03.005_bib56","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.7150\/ijbs.61950","article-title":"Single-cell RNA sequencing deconvolutes the in\u00a0vivo heterogeneity of human bone marrow-derived mesenchymal stem cells","volume":"17","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cmet.2024.03.005_bib57","first-page":"15595","article-title":"Single-cell RNA sequencing of human femoral head in\u00a0vivo","volume":"13","author":"Qiu","year":"2021","journal-title":"Aging (Albany, N.Y.)"}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413124000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413124000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:30:13Z","timestamp":1783027813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413124000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1550413124000846"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2024.03.005","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2024.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}